226 Results for "

first-in-class

" in MedChemExpress (MCE) Product Catalog:
Products (226)

226 Results for "first-in-class" in MCE Product Catalog:

121
121 Publications Verification
Cat. No.: HY-114277
CAS No.: 2296729-00-3
Purity:  99.94%
Synonyms: AMG-510
Target:  

Ras

Research Areas:  

Cancer

Sotorasib (AMG-510) is a first-in-class, orally bioavailable, and selective KRAS G12C covalent inhibitor. Sotorasib irreversibly inhibits KRAS G12C by locking it in an inactive GDP-bound state. Sotorasib leads to the regression of KRAS G12C‑mutated locally advanced or metastatic non‑small cell lung cancer (NSCLC) .
loading...
    loading...
113
113 Cited Publications
Cat. No.: HY-134836
CAS No.: 2499663-01-1
Purity:  99.86%
Target:  

Apoptosis METTL3

Research Areas:  

Cancer

STM2457 is a first-in-class, highly potent, selective and orally active METTL3 inhibitor with an IC50 of 16.9 nM. STM2457 can be used for the research of acute myeloid leukaemia (AML) .
loading...
    loading...
110
110 Cited Publications
Cat. No.: HY-12248
CAS No.: 1439399-58-2
Purity:  99.82%
Synonyms: CB-839
Target:  

Glutaminase Autophagy

Research Areas:  

Cancer

Telaglenastat (CB-839) is a first-in-class, selective, reversible and orally active glutaminase 1 (GLS1) inhibitor. Telaglenastat selectively inhibits GLS1 splice variants KGA (kidney-type glutaminase) and GAC (glutaminase C) compared to GLS2. The IC50s are 23 nM and 28 nM for endogenous glutaminase in mouse kidney and brain, respectively. Telaglenastat inuduces autophagy and has antitumor activity .
loading...
    loading...
110
110 Cited Publications
Cat. No.: HY-12248A
CAS No.: 1874231-60-3
Synonyms: CB-839 hydrochloride
Target:  

Glutaminase Autophagy

Research Areas:  

Cancer

Telaglenastat (CB-839) hydrochloride is a first-in-class, selective, reversible and orally active glutaminase 1 (GLS1) inhibitor. Telaglenastat hydrochloride selectively inhibits GLS1 splice variants KGA (kidney-type glutaminase) and GAC (glutaminase C) compared to GLS2. The IC50s are 23 nM and 28 nM for endogenous glutaminase in mouse kidney and brain, respectively. Telaglenastat hydrochloride inudces autophagy and has antitumor activity .
loading...
    loading...
104
104 Cited Publications
Cat. No.: HY-12057
CAS No.: 918504-65-1
Purity:  99.85%
Synonyms: PLX4032; RG7204; RO5185426
Target:  

Raf Autophagy

Research Areas:  

Cancer

Vemurafenib (PLX4032) is a first-in-class, selective, potent inhibitor of B-RAF kinase, with IC50s of 31 and 48 nM for RAF V600E and c-RAF-1, respectively . Vemurafenib induces cell autophagy .
loading...
    loading...
89
89 Cited Publications
Cat. No.: HY-100487
CAS No.: 1450833-55-2
Purity:  98.38%
Synonyms: MLN7243
Research Areas:  

Cancer

TAK-243 (MLN7243) is a first-in-class, selective ubiquitin activating enzyme, UAE (UBA1) inhibitor (IC50=1 nM), which blocks ubiquitin conjugation, disrupting monoubiquitin signaling as well as global protein ubiquitination. TAK-243 (MLN7243) induces endoplasmic reticulum (ER) stress, abrogates NF-κB pathway activation and promotes apoptosis .
loading...
    loading...
58
58 Cited Publications
Cat. No.: HY-134813
CAS No.: 2621928-55-8
Purity:  99.97%
Target:  

Ras

Research Areas:  

Cancer

MRTX1133 is a noncovalent, potent, and selective alkyne-based KRAS G12D inhibitor. MRTX1133 optimally fills the switch II pocket and extends three substituents to favorably interact with the protein, resulting in an estimated KD against KRAS G12D of 0.2 pM. MRTX1133 prevents SOS1-catalyzed nucleotide exchange and/or formation of the KRAS G12D/GTP/RAF1 complex, thereby inhibiting mutant KRAS-dependent signal transduction. MRTX1133 selectively inhibits KRAS G12D mutant, but not KRAS wild-type, tumor cells. MRTX1133 has single digit nanomolar activity in cellular assays and marked in vivo efficacy in tumor models harboring KRAS G12D mutations .
loading...
    loading...
53
53 Cited Publications
Cat. No.: HY-12861
CAS No.: 1542705-92-9
Purity:  99.90%
Target:  

p97

Research Areas:  

Cancer

CB-5083 is a first-in-class, potent, selective, and orally bioavailable inhibitor of the p97 AAA ATPase/VCP. CB-5083 selectively inhibits p97 through its D2 site with the IC50 of 11 nM .
loading...
    loading...
50
50 Cited Publications
Cat. No.: HY-109025A
CAS No.: 1985605-59-1
Purity:  99.68%
Synonyms: Baloxavir acid; S-033447
Target:  

Influenza Virus

Research Areas:  

Infection Cancer

Baloxavir (Baloxavir acid), derived from the proagent Baloxavir marboxil, is a first-in-class, potent and selective cap-dependent endonuclease (CEN) inhibitor within the polymerase PA subunit of influenza A and B viruses. Baloxavir inhibits viral RNA transcription and replication and has potently antiviral activity .
loading...
    loading...
37
37 Cited Publications
Cat. No.: HY-12481
CAS No.: 1523406-39-4
Purity:  99.74%
Target:  

PI3K Autophagy

Research Areas:  

Cancer

SAR405 is a first-in-class, selective, and ATP-competitive PI3K class III (PIK3C3) isoform Vps34 inhibitor (IC50=1.2 nM; Kd=1.5 nM). SAR405 inhibits autophagy induced either by starvation or by mTOR inhibition. Anticancer activity .
loading...
    loading...
34
34 Cited Publications
Cat. No.: HY-111789
CAS No.: 1858276-04-6
Purity:  98.56%
Synonyms: TAK-981
Target:  

E1/E2/E3 Enzyme

Research Areas:  

Inflammation/Immunology Cancer

Subasumstat (TAK-981) is a first in class and selective inhibitor of the SUMOylation enzymatic cascade, with potential immune-activating and antineoplastic activities .
loading...
    loading...
33
33 Cited Publications
Cat. No.: HY-14865
CAS No.: 389139-89-3
Purity:  99.85%
Synonyms: PTK 0796; Amadacycline
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

Omadacycline (PTK 0796), a first-in-class orally active aminomethylcycline antibacterial, is a member of the tetracycline class of antibiotics. Omadacycline acts through the inhibition of bacterial protein synthesis by binding to the 30S ribosomal subunit. Omadacycline possesses broad-spectrum antibacterial activity against aerobic and anaerobic Gram-positive and Gram-negative bacteria, as well as atypical bacteria. Omadacycline can be used for the research of acute bacterial skin and skin-structure infections, community-acquired pneumonia, and urinary tract infections .
loading...
    loading...
33
33 Cited Publications
Cat. No.: HY-14865B
CAS No.: 1075240-43-5
Purity:  99.37%
Synonyms: PTK 0796 tosylate; Amadacycline tosylate
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

Omadacycline (PTK 0796) tosylate, a first-in-class orally active aminomethylcycline antibacterial, is a member of the tetracycline class of antibiotics. Omadacycline tosylate acts through the inhibition of bacterial protein synthesis by binding to the 30S ribosomal subunit. Omadacycline tosylate possesses broad-spectrum antibacterial activity against aerobic and anaerobic Gram-positive and Gram-negative bacteria, as well as atypical bacteria. Omadacycline tosylate can be used for the research of acute bacterial skin and skin-structure infections, community-acquired pneumonia, and urinary tract infections .
loading...
    loading...
33
33 Cited Publications
Cat. No.: HY-14865C
CAS No.: 1196800-39-1
Purity:  99.47%
Synonyms: PTK0796 hydrochloride; Amadacycline hydrochloride
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

Omadacycline (PTK 0796) hydrochloride, a first-in-class orally active aminomethylcycline antibacterial, is a member of the tetracycline class of antibiotics. Omadacycline hydrochloride acts through the inhibition of bacterial protein synthesis by binding to the 30S ribosomal subunit. Omadacycline hydrochloride possesses broad-spectrum antibacterial activity against aerobic and anaerobic Gram-positive and Gram-negative bacteria, as well as atypical bacteria. Omadacycline hydrochloride can be used for the research of acute bacterial skin and skin-structure infections, community-acquired pneumonia, and urinary tract infections .
loading...
    loading...
28
28 Cited Publications
Cat. No.: HY-120934
CAS No.: 1358099-18-9
Purity:  99.92%
Research Areas:  

Inflammation/Immunology

C25-140, a first-in-class, orally active, and fairly selective TRAF6-Ubc13 inhibitor, directly binds to TRAF6, and blocks the interaction of TRAF6 with Ubc13. C25-140 lowers TRAF6 activity, reduces NF-κB activation, and combats autoimmunity .
loading...
    loading...
24
24 Cited Publications
Cat. No.: HY-15262
CAS No.: 1093403-33-8
Purity:  99.00%
SRT 2104 is a first-in-class, highly selective and brain-permeable activator of the NAD + dependent deacetylase Sirt1, increases Sirt1 protein, but shows no effect on Sirt1 mRNA. Used in the research of diabetes mellitus and Huntington’s disease .
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-18690A
CAS No.: 1650550-25-6
Synonyms: AG-221 mesylate
Research Areas:  

Cancer

Enasidenib mesylate is a first-in-class, oral, potent, reversible, selective inhibitor of the IDH2 mutant enzymes.
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-139664
CAS No.: 2170137-61-6
Purity:  99.95%
Target:  

DNA Methyltransferase

Research Areas:  

Cancer

GSK-3685032 is a non-time-dependent, noncovalently, first-in-class reversible DNMT1-selective inhibitor, with an IC50 of 0.036 μM. GSK-3685032 induces robust loss of DNA methylation, transcriptional activation, and cancer cell growth inhibition .
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-139396
CAS No.: 2242952-69-6
Purity:  99.96%
Research Areas:  

Inflammation/Immunology Cancer

BMS-986299 (compound 112) is a first-in-class NLRP3 inflammasome agonist with an EC50 of 1.28 μM. (patent WO2018152396A1).
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-12484
CAS No.: 896705-16-1
Purity:  99.25%
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

BMH-21 is a first-in-class DNA intercalator which inhibits RNA polymerase I (Pol I) transcription. BMH-21 possesses anticancer activity .
loading...
    loading...